An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura

被引:83
作者
Joly, Berangere S. [1 ,2 ]
Coppo, Paul [3 ]
Veyradier, Agnes [1 ,2 ]
机构
[1] Univ Paris Dider, Grp Hosp St Louis Lariboisiere, AP HP, Serv Hematol Biol,Inst Univ Hematol, Paris, France
[2] Univ Paris Dider, Grp Hosp St Louis Lariboisiere, AP HP, Ctr Hayem EA3518,Inst Univ Hematol, Paris, France
[3] Univ Sorbonne Paris Cite, Hop St Antoine, AP HP, Serv Hematol, Paris, France
关键词
Thrombotic microangiopathy; thrombotic thrombocytopenic purpura; ADAMTS13; von Willebrand factor; autoimmunity; rare disease; VON-WILLEBRAND-FACTOR; FACTOR-CLEAVING PROTEASE; SEVERE ADAMTS13 DEFICIENCY; FRENCH NATIONAL REGISTRY; UPSHAW-SCHULMAN SYNDROME; MOLECULAR CHARACTERIZATION; CONFORMATIONAL ACTIVATION; ANTI-ADAMTS13; ANTIBODIES; PLASMA-EXCHANGE; FACTOR-VIII;
D O I
10.1080/17474086.2019.1611423
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Thrombotic thrombocytopenic purpura (TTP) is a rare and life-threatening thrombotic microangiopathy characterized by microangiopathic hemolytic anemia, consumption thrombocytopenia, and organ injury. TTP pathophysiology is based on a severe ADAMTS13 deficiency, the specific von Willebrand factor (VWF)-cleaving protease. Areas covered: VWF/ADAMTS13 interaction is specific, and ADAMTS13 conformation has been elucidated recently. ADAMTS13 deficiency is congenital or acquired. Several targets are used in TTP treatment. Expert opinion: Differential diagnosis of TTP may be challenging and ADAMTS13 investigations are needed. ADAMTS13 conformation could be a promising parameter for TTP diagnosis and prognosis in the coming years. Plasma therapy remains the first-line treatment of the acute phase of TTP. Additional curative and preemptive rituximab are used in acquired TTP. Clinical trials dedicated to innovative drugs are promising.
引用
收藏
页码:383 / 395
页数:13
相关论文
共 80 条
  • [1] IMMUNOHISTOCHEMISTRY OF VASCULAR LESION IN THROMBOTIC THROMBOCYTOPENIC PURPURA, WITH SPECIAL REFERENCE TO FACTOR-VIII RELATED ANTIGEN
    ASADA, Y
    SUMIYOSHI, A
    HAYASHI, T
    SUZUMIYA, J
    KAKETANI, K
    [J]. THROMBOSIS RESEARCH, 1985, 38 (05) : 469 - 479
  • [2] Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study
    Bendapudi, Pavan K.
    Hurwitz, Shelley
    Fry, Ashley
    Marques, Marisa B.
    Waldo, Stephen W.
    Li, Ang
    Sun, Lova
    Upadhyay, Vivek
    Hamdan, Ayad
    Brunner, Andrew M.
    Gansner, John M.
    Viswanathan, Srinivas
    Kaufman, Richard M.
    Uhl, Lynne
    Stowell, Christopher P.
    Dzik, Walter H.
    Makar, Robert S.
    [J]. LANCET HAEMATOLOGY, 2017, 4 (04): : E157 - E164
  • [3] Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center
    Benhamou, Y.
    Boelle, P-Y
    Baudin, B.
    Ederhy, S.
    Gras, J.
    Galicier, L.
    Azoulay, E.
    Provot, F.
    Maury, E.
    Pene, F.
    Mira, J. -P.
    Wynckel, A.
    Presne, C.
    Poullin, P.
    Halimi, J. -M.
    Delmas, Y.
    Kanouni, T.
    Seguin, A.
    Mousson, C.
    Servais, A.
    Bordessoule, D.
    Perez, P.
    Hamidou, M.
    Cohen, A.
    Veyradier, A.
    Coppo, P.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (02) : 293 - 302
  • [4] Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study
    Benhamou, Ygal
    Paintaud, Gilles
    Azoulay, Elie
    Poullin, Pascale
    Galicier, Lionel
    Desvignes, Celine
    Baudel, Jean-Luc
    Peltier, Julie
    Mira, Jean-Paul
    Pene, Frederic
    Presne, Claire
    Saheb, Samir
    Deligny, Christophe
    Rousseau, Alexandra
    Feger, Frederic
    Veyradier, Agnes
    Coppo, Paul
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (12) : 1246 - 1251
  • [5] Are platelet transfusions harmful in acquired thrombotic thrombocytopenic purpura at the acute phase? experience of the French thrombotic microangiopathies reference center
    Benhamou, Ygal
    Baudel, Jean-Luc
    Wynckel, Alain
    Galicier, Lionel
    Azoulay, Elie
    Provor, Francois
    Pene, Frederic
    Mira, Jean-Paul
    Presne, Claire
    Poullin, Pascale
    Halimi, Jean-Michel
    Riviere, Etienne
    Kanouni, Tarik
    Seguin, Amelie
    Mousson, Christiane
    Servais, Aude
    Bordessoule, Dominique
    Perez, Pierre
    Hamidou, Mohamed
    Chauveau, Dominique
    Veyradier, Agnes
    Coppo, Paul
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (06) : E127 - E129
  • [6] ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
    Bettoni, G.
    Palla, R.
    Valsecchi, C.
    Consonni, D.
    Lotta, L. A.
    Trisolini, S. M.
    Mancini, I.
    Musallam, K. M.
    Rosendaal, F. R.
    Peyvandi, F.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (08) : 1556 - 1565
  • [7] Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry
    Blombery, P.
    Kivivali, L.
    Pepperell, D.
    McQuilten, Z.
    Engelbrecht, S.
    Polizzotto, M. N.
    Phillips, L. E.
    Wood, E.
    Cohney, S.
    [J]. INTERNAL MEDICINE JOURNAL, 2016, 46 (01) : 71 - 79
  • [8] Camilleri RS, 2008, J THROMB HAEMOST, V6, P331, DOI 10.1111/j.1538-7836.2008.02846.x
  • [9] A phenotype-genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom
    Camilleri, R. S.
    Scully, M.
    Thomas, M.
    Mackie, I. J.
    Liesner, R.
    Chen, W. J.
    Manns, K.
    Machin, S. J.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (09) : 1792 - 1801
  • [10] N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice
    Chen, Junmei
    Reheman, Adili
    Gushiken, Francisca C.
    Nolasco, Leticia
    Fu, Xiaoyun
    Moake, Joel L.
    Ni, Heyu
    Lopez, Jose A.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (02) : 593 - 603